Pharmaceutical Scientists are at the forefront of discovering, developing, and optimizing new medications that improve human health. They combine knowledge from chemistry, biology, and pharmacology to understand how drugs interact with biological systems. These professionals are deeply involved in various stages of drug development—from identifying active compounds and studying their effects in the lab to formulating them into safe, effective dosage forms. They also ensure that medications meet quality standards and regulatory guidelines before reaching the market. Their work is critical in advancing therapeutic innovation and addressing unmet medical needs. Without their expertise, many of today’s life-saving medications would never make it past the lab bench.
In today’s rapidly evolving pharmaceutical landscape, the role of pharmaceutical scientists continues to expand. With advancements in biotechnology, nanotechnology, and personalized medicine, these experts are developing targeted therapies and that offer improved outcomes and fewer side effects. Pharmaceutical scientists also collaborate with clinicians, regulatory agencies, and manufacturing teams to ensure that the transition from research to patient care is seamless. Their commitment to scientific excellence and patient safety plays a vital role in the global effort to combat diseases and improve quality of life. As medicine becomes more specialized and technology-driven, pharmaceutical scientists remain essential to shaping the future of healthcare.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia